Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Pluronic P85/poly(lactic Acid) Vesicles As Novel Carrier For Oral Insulin Delivery.

X. Y. Xiong, Q. Li, Y. P. Li, L. Guo, Zi Ling Li, Y. Gong
Published 2013 · Chemistry, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Poly(lactic acid)-b-Pluronic-b-poly(lactic acid) (PLA-P85-PLA) vesicles were developed as novel carrier for oral insulin delivery. PLA-P85-PLA block copolymer was synthesized by ring opening polymerization of the monomer l-lactide using Pluronic copolymer P85 as the initiator. Insulin-loaded PLA-P85-PLA vesicles were prepared by dialysis method and the mean diameter of insulin-loaded PLA-P85-PLA vesicles was determined to be 178 nm. The cytotoxicity studies using human ovarian cancer cells OVCAR-3 indicate that PLA-P85-PLA block copolymer has good biocompatibility. Both in vitro and in vivo release behavior of insulin loaded in PLA-P85-PLA vesicles were studied. It was observed that insulin was released out gradually from PLA-P85-PLA vesicles and almost all insulin was released out 7.5h later. More importantly, for the oral administration of insulin-loaded PLA-P85-PLA vesicles at insulin doses of 200 IU/kg, the minimum blood glucose concentration was observed in the diabetic mice test after 2.5h, which was 15% of initial glucose level. Furthermore, the blood glucose concentration increased slowly to 31.8% of initial blood glucose concentration after 10.5h and was maintained at this level for at least an additional 14h (32.5% of initial blood glucose concentration at 24.5h). These results proved that PLA-P85-PLA vesicles could be promising polymeric carriers for oral insulin delivery application due to their sustained and enhanced hypoglycemic effect.
This paper references
10.1016/j.ejps.2010.08.009
Pharmacological effect of orally delivered insulin facilitated by multilayered stable nanoparticles.
Camile B. Woitiski (2010)
10.1016/j.ejps.2012.06.020
Methylated N-(4-N,N-dimethylaminobenzyl) chitosan coated liposomes for oral protein drug delivery.
Jariya Kowapradit (2012)
10.1016/j.biomaterials.2011.08.087
A review of the prospects for polymeric nanoparticle platforms in oral insulin delivery.
M. Chen (2011)
10.2147/IJN.S38507
Nanoemulsions coated with alginate/chitosan as oral insulin delivery systems: preparation, characterization, and hypoglycemic effect in rats
X. Li (2013)
10.1166/JNN.2006.416
Oral administration of liposomal insulin.
I. T. Değim (2006)
10.1016/J.JCONREL.2007.04.004
Vesicles from Pluronic/poly(lactic acid) block copolymers as new carriers for oral insulin delivery.
X. Y. Xiong (2007)
10.1023/A:1016009313548
Enteral Absorption of Insulin in Rats from Mucoadhesive Chitosan-Coated Liposomes
H. Takeuchi (2004)
10.1016/J.PROGPOLYMSCI.2012.04.004
Strategies for effective oral insulin delivery with modified chitosan nanoparticles: A review
Piyasi Mukhopadhyay (2012)
10.1016/j.ejpb.2012.02.009
Hypoglycemic activity and oral bioavailability of insulin-loaded liposomes containing bile salts in rats: the effect of cholate type, particle size and administered dose.
M. Niu (2012)
10.1016/j.colsurfb.2012.11.012
Biocompatibility, cellular uptake and biodistribution of the polymeric amphiphilic nanoparticles as oral drug carriers.
Y. Liu (2013)
10.1016/j.ejpb.2012.07.014
pH-sensitive polymeric nanoparticles to improve oral bioavailability of peptide/protein drugs and poorly water-soluble drugs.
Xue-qing Wang (2012)
10.1002/JBM.B.30372
Novel pH responsive polymethacrylic acid-chitosan-polyethylene glycol nanoparticles for oral peptide delivery.
S. Sajeesh (2006)
10.1016/j.ijpharm.2011.12.055
HP55-coated capsule containing PLGA/RS nanoparticles for oral delivery of insulin.
Z. M. Wu (2012)
10.1016/j.jconrel.2011.06.009
Advanced molecular design of biopolymers for transmucosal and intracellular delivery of chemotherapeutic agents and biological therapeutics.
William B. Liechty (2011)
, pHsensitive polymeric nanoparticles to improve oral bioavailability of peptide / protein drugs and poorly water - soluble drugs
Q. Zhang (2012)
10.1016/j.biomaterials.2011.10.075
Goblet cell-targeting nanoparticles for oral insulin delivery and the influence of mucus on insulin transport.
Y. Jin (2012)
10.2217/NNM.12.31
Folate-decorated PLGA nanoparticles as a rationally designed vehicle for the oral delivery of insulin.
S. Jain (2012)
10.1586/erd.09.43
Challenges and advances in nanoparticle-based oral insulin delivery
Rekha M Ramesan (2009)
10.1016/j.biomaterials.2010.01.045
Polymer integrity related absorption mechanism of superporous hydrogel containing interpenetrating polymer networks for oral delivery of insulin.
Lichen Yin (2010)
10.3109/08982104.2011.621128
Effectiveness of submicronized chitosan-coated liposomes in oral absorption of indomethacin
H. Sugihara (2012)
10.1016/j.ejps.2010.12.007
Design and evaluation of novel pH-sensitive chitosan nanoparticles for oral insulin delivery.
Abdallah Makhlof (2011)
10.1016/j.ejpb.2010.09.016
Preparation and evaluation of alginate-chitosan microspheres for oral delivery of insulin.
Y. Zhang (2011)
10.1016/J.JCONREL.2006.10.023
Oral delivery of insulin associated to polymeric nanoparticles in diabetic rats.
C. Damgé (2007)
10.1016/j.bmcl.2012.04.108
Synthesis of chalcone derivatives as potential anti-diabetic agents.
Chi-Ting Hsieh (2012)
10.1016/j.colsurfb.2012.01.029
Solvent mediated microstructures and release behavior of insulin from pH-sensitive nanoparticles.
Z. M. Wu (2012)
10.1016/j.biomaterials.2010.05.042
Biodistribution, pharmacodynamics and pharmacokinetics of insulin analogues in a rat model: Oral delivery using pH-responsive nanoparticles vs. subcutaneous injection.
K. Sonaje (2010)
10.1111/j.1365-3156.2011.02808.x
Applying lessons learnt from the ‘DOTS’ Tuberculosis Model to monitoring and evaluating persons with diabetes mellitus in Blantyre, Malawi
T. Allain (2011)
10.1081/PDT-100100522
Mucoadhesive DL-Lactide/Glycolide Copolymer Nanospheres Coated with Chitosan to Improve Oral Delivery of Elcatonin
Y. Kawashima (2000)
10.1016/j.diabres.2011.12.001
Rural diabetes prevalence quintuples over twenty-five years in low- and middle-income countries: a systematic review and meta-analysis.
C. K. Hwang (2012)
10.1016/j.ijpharm.2010.04.006
Effective protection and controlled release of insulin by cationic beta-cyclodextrin polymers from alginate/chitosan nanoparticles.
N. Zhang (2010)
10.1021/BC025504W
Design and formulation of polyplexes based on pluronic-polyethyleneimine conjugates for gene transfer.
C. Gebhart (2002)
Preparation and evaluation of alginate – chitosan microspheres for oral delivery of insulin , Eur
W. Wei Y. Zhang (2011)



This paper is referenced by
10.1007/s10847-015-0576-x
Theoretical investigation on insulin dimer-β-cyclodextrin interactions using docking and molecular dynamics simulation
Erma Fatiha Muhammad (2015)
10.1007/s11051-014-2847-7
pH-sensitive thiolated nanoparticles facilitate the oral delivery of insulin in vitro and in vivo
Y. Zhang (2015)
10.1016/j.jcis.2016.04.004
Intact deposition of cationic vesicles on anionic cellulose fibers: Role of vesicle size, polydispersity, and substrate roughness studied via streaming potential measurements.
A. Kumar (2016)
10.1016/j.drudis.2014.04.011
Is nanotechnology a boon for oral drug delivery?
Udita Agrawal (2014)
10.1016/j.colsurfb.2015.01.035
Surface engineered and ligand anchored nanobioconjugate: an effective therapeutic approach for oral insulin delivery in experimental diabetic rats.
R. Sharma (2015)
10.3109/21691401.2014.975239
Proteins and peptides: The need to improve them as promising therapeutics for ulcerative colitis
K. Sahu (2016)
10.1016/j.msec.2016.07.017
Facile preparation of pH-responsive polyurethane nanocarrier for oral delivery.
M. R. Nabid (2016)
10.1016/j.ijbiomac.2017.07.085
The targeting properties of folate-conjugated Pluronic F127/poly (lactic-co-glycolic) nanoparticles.
Y. Luo (2017)
10.15412/J.JBTW.01030905
Control, Management and Treatment of Diabetes Using Modern Drug Delivery Systems and Special Properties of Nanoparticles
Mahnaz Rezaei-kelishadi (2014)
10.1080/1061186X.2017.1300664
Intestinal micropatches for oral insulin delivery
Amrita Banerjee (2017)
10.1016/J.PMATSCI.2017.05.001
Functionalized materials for multistage platforms in the oral delivery of biopharmaceuticals
Francisca Araújo (2017)
10.2174/1389201015666140915150826
Therapeutic nanosystems for oral administration of insulin.
F. A. do Carmo (2014)
10.1007/S12668-016-0254-5
A Genome-Wide Analysis of mRNA Expression in Human Tooth Germ Stem Cells Treated with Pluronic P85
Atousa Ataei (2016)
Self- Assembled Chitosan-g-Pluronic F-127 Copolymer (ChPC) Loaded with Polydatin Nanoparticles: Implication as Anti-Diabetic Therapy
Xiaoling Tian (2020)
10.3109/10717544.2015.1052863
A review of biodegradable polymeric systems for oral insulin delivery
Y. Luo (2016)
10.4155/tde-2017-0106
Targeted delivery of puerarin/glycyrrhetinic acid-PEG-PBLA complex attenuated liver ischemia/reperfusion injury via modulating Toll-like receptor 4/nuclear factor-κB pathway.
Y. Xiao (2018)
10.1049/MNL.2013.0461
Acute and subacute toxicity studies of Pluronic P85/poly (lactic acid) nanoparticles in mice
L. Yu-ping (2013)
10.1016/j.biotechadv.2015.02.010
Polymer-based nanoparticles for oral insulin delivery: Revisited approaches.
P. Fonte (2015)
Development of a boronic acid sensor-based glucose-responsive nanoparticulate insulin delivery system
Nabil Ahmad Siddiqui (2017)
10.1049/MNL.2016.0690
Synthesis, characterisation and in vitro release of paclitaxel-loaded polymeric micelles
Z. Li (2017)
10.1016/j.ejmech.2014.08.067
Current research on hyaluronic acid-drug bioconjugates.
Haiqun Zhang (2014)
10.2147/IJN.S146546
In vitro and in vivo protein release and anti-ischemia/reperfusion injury properties of bone morphogenetic protein-2-loaded glycyrrhetinic acid-poly(ethylene glycol)-b-poly(l-lysine) nanoparticles
F. Shan (2017)
10.1002/adtp.202000186
A review of the current state of nanomedicines for targeting and treatment of cancers - achievements and future challenges
Ali Kermanizadeh (2020)
10.2147/IJN.S177418
Nanodelivery systems and stabilized solid-drug nanoparticles for orally administered medicine: current landscape
A. Kermanizadeh (2018)
10.2217/nnm-2017-0372
Targeted folate-conjugated pluronic P85/poly(lactide-co-glycolide) polymersome for the oral delivery of insulin.
S. Xie (2018)
10.1158/0008-5472.CAN-13-2015
Novel polymeric nanoparticles for intracellular delivery of peptide Cargos: antitumor efficacy of the BCL-2 conversion peptide NuBCP-9.
M. Kumar (2014)
10.3390/polym11111880
The Influence of Mucin-Based Artificial Saliva on Properties of Polycaprolactone and Polylactide
Dawid Łysik (2019)
10.1016/j.csbj.2019.09.004
Recent Advancements in Non-Invasive Formulations for Protein Drug Delivery
Rajiv Bajracharya (2019)
10.25082/JPBR.2019.02.005
Developments in encapsulation of insulin: Is oral delivery now possible?
A. Singh (2019)
10.1016/j.jconrel.2017.09.025
Animal models for evaluation of oral delivery of biopharmaceuticals
Stine Harloff-Helleberg (2017)
Semantic Scholar Logo Some data provided by SemanticScholar